Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report.
EGFR
furmonertinib
nimotuzumab
pancreatic cancer
targeted therapy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
01
2023
accepted:
28
03
2023
medline:
24
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
epublish
Résumé
Pancreatic cancer is the leading cause of cancer death, and treatment options are limited and mostly ineffective. The patient we report had an
Identifiants
pubmed: 37091175
doi: 10.3389/fonc.2023.1151178
pmc: PMC10117981
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1151178Informations de copyright
Copyright © 2023 Ma, Liu, Ou, Zhang, Gao and Yang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet Oncol. 2020 Apr;21(4):508-518
pubmed: 32135080
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Clin Oncol. 2007 May 20;25(15):1960-6
pubmed: 17452677
Nature. 2015 Feb 26;518(7540):495-501
pubmed: 25719666
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Gastroenterology. 2012 Apr;142(4):730-733.e9
pubmed: 22226782
Int J Mol Sci. 2019 Sep 11;20(18):
pubmed: 31514451
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Exp Clin Cancer Res. 2020 Oct 28;39(1):227
pubmed: 33115526
Nat Rev Clin Oncol. 2022 Aug;19(8):499-514
pubmed: 35534623
Cell Res. 2019 Sep;29(9):725-738
pubmed: 31273297
Clin Cancer Res. 2012 Aug 15;18(16):4266-76
pubmed: 22896693
World J Gastroenterol. 2018 Nov 21;24(43):4846-4861
pubmed: 30487695
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Front Oncol. 2021 Sep 06;11:724815
pubmed: 34568053
Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11
pubmed: 25355519
Nat Rev Clin Oncol. 2020 Feb;17(2):108-123
pubmed: 31705130
Ann Oncol. 2017 Oct 01;28(10):2429-2435
pubmed: 28961832
Mod Pathol. 2005 Jul;18(7):959-63
pubmed: 15832197
J Clin Oncol. 2010 Aug 1;28(22):3605-10
pubmed: 20606093
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nat Commun. 2015 Apr 09;6:6744
pubmed: 25855536
Curr Drug Targets. 2012 Jun;13(6):802-10
pubmed: 22458527
Clin Cancer Res. 2022 Jun 13;28(12):2704-2714
pubmed: 35302596
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
J Clin Oncol. 2011 Jul 20;29(21):2866-74
pubmed: 21670455